Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 13576 - 13600 of 14521 in total

Listeria monocytogenes

Investigational

RAD 502

Investigational

Imvotamab

Investigational

IMGN632

Investigational

Maveropepimut-S

Maveropepimut-S is a T cell activating immunotherapy.
Investigational

ICG-136

ICG-136 is a compound chimeric antigen receptor (cCAR) T-cell therapy developed by iCell Gene Therapeutics. It was investigated for the treatment of acute myeloid leukemia.
Investigational

LSTA1

Investigational

AIC100

Investigational

WT-1 427 long

Investigational

WT-1 331 long

Investigational

TALL-104

Investigational

Obecabtagene autoleucel

Obecabtagene autoleucel is an investigational autologous CD19 CAR T cell therapy.
Investigational

AMG-119

AMG-119 are CAR-T cells targeting delta-like ligand 3 (DLL3).
Investigational

Gavocabtagene autoleucel

Gavocabtagene autoleucel is a novel cell therapy consisting of autologous genetically engineered T cells expressing a single-domain antibody that recognizes human Mesothelin, fused to the CD3-epsilon subunit which, upon expression, is incorporated into the endogenous T cell receptor (TCR) complex.
Investigational

TBX-3400

TBX-3400 is an investigational cell-based immunotherapy consisting of autologous peripheral blood mononuclear cells (PBMCs) treated ex vivo with TBX-4000, which is a recombinant TAT-MYC fusion protein.[L44281,L44286]
Investigational

Human Recombinant Bone Morphogenetic Protein 4

Investigational

Ferritarg P

Investigational

Trastuzumab vedotin

Investigational

Immucin

Investigational

LuLym-T

LuLym-T is an investigational autologous immune cell therapy consisting of activated T Lymphocytes. Developed by Lukas Biomedical, Inc., it is currently being investigated in hepatocellular carcinoma.
Investigational

KITE-585

KITE-585 is an autologous, fully-human anti-B cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T cell therapy. It is being investigated in the treatment of multiple myeloma.
Investigational

BS-001

BS-001 is a recombinant oncolytic herpes simplex virus type II (OH2) therapeutic injection (Vero cell) for human use (rHSV2hGM-CSF).
Investigational

DCP-001

Investigational

BI-1206

BI-1206 is a fully human immunoglobulin G1 monoclonal antibody that targets CD32b.
Investigational

MT-0169

MT-0169 is a usion protein comprised of an enzymatically active Shiga-like toxin-I A1 subunit fused to a human single chain variable fragment with affinity for human CD38 cell surface protein.
Investigational
Displaying drugs 13576 - 13600 of 14521 in total